Hemodynamic improvement is faster after percutaneous ASD closure than after surgery

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 3, 2007, Pages 432-441

  Eerola, Anneli ^a,b,d   Pihkala, Jaana I ^b   Boldt, Talvikki ^b   Mattila, Ilkka P ^b   Poutanen, Tuija ^c   Jokinen, Eero ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Atrial septal defect; Echocardiography; Natriuretic peptides; Percutaneous closure; Surgery

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CEFUROXIME; HEPARIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; PERCUTANEOUS CLOSURE; POSTOPERATIVE INFECTION; STERNOTOMY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HEART VENTRICLES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 33847419201     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20962     Document Type: Article

References (43)

1. Veldtman GR, Freedom RM, Benson LN. Atrial septal defect. In: Freedom RM, Yoo S-J, Mikailian H, Williams WG, editors. The Natural and Modified History of congenital Heart Disease, Vol. 1. Oxford: Blackwell; 2004. pp 31-43.
2. Campbell M. Natural history of atrial septal defect. Br Heart J 1970;32:820-826.
3. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171-185; passim.
4. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976;235:2506-2509.
5. Butera G, De Rosa G, Chessa M, Rosti L, Negura DG, Luciane P, Giamberti A, Bossone E, Carminati M. Transcatheter closure of atrial septal defect in young children: Results and follow-up. J Am Coll Cardiol 2003;42:241-245.
6. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pome G, Bossone E, Frigiola A. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-1065.
7. Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC, Webb G, Therrien J. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J Am Coll Cardiol 2005;45:499-504.
8. Shaheen J, Alper L, Rosenmann D, Klutstein MW, Falkowsky G, Bitran D, Tzivoni D. Effect of surgical repair of secundum-type atrial septal defect on right atrial, right ventricular, and left ventricular volumes in adults. Am J Cardiol 2000;86:1395-1397, A6.
9. Walker RE, Moran AM, Gauvreau K, Colan SD. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol 2004;93:1374-1377, A6.
10. Keller AM. Positional localization: Three-dimensional transthoracic echocardiographic techniques for the measurement of cardiac mass, volume, and function. Echocardiography 2000;17:745-748.
11. De Castro S, Yao J, Pandian NG. Three-dimensional echocardiography: Clinical relevance and application. Am J Cardiol 1998;81:96G-102G.
12. Sapin PM, Schroder KM, Gopal AS, Smith MD, DeMaria AN, King DL. Comparison of two- and three-dimensional echocardiography with cineventriculography for measurement of left ventricular volume in patients. J Am Coll Cardiol 1994;24:1054-1063.
13. Acar P, Maunoury C, Antonietti T, Bonnet D, Sidi D, Kachaner J. Left ventricular ejection fraction in children measured by three-dimensional echocardiography using a new transthoracic integrated 3D-probe. A comparison with equilibrium radionuclide angiography. Eur Heart J 1998;19:1583-1588.
14. Nosir YF, Lequin MH, Kasprzak JD, van Domburg RT, Vletter WB, Yao J, Stoker J, Ten Cate FJ, Roelandt JR. Measurements and day-to-day variabilities of left ventricular volumes and ejection fraction by three-dimensional echocardiography and comparison with magnetic resonance imaging. Am J Cardiol 1998;82:209-124.
15. Poutanen T, Ikonen A, Jokinen E, Vainio P, Tikanoja T. Transthoracic three-dimensional echocardiography is as good as magnetic resonance imaging in measuring dynamic changes in left ventricular volume during the heart cycle in children. Eur J Echocardiogr 2001;2:31-39.
16. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-328.
17. Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 2004;93:340-345.
18. Mir TS, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002;110:e76.
19. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004;25:336-340.
20. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-385.
21. Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 2001;19:557-571.
22. Poutanen T, Tikanoja T, Riikonen P, Silvast A, Perkkio M. Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children. J Clin Oncol 2003;21:2349-2356.
23. Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF, Huth RG, Habermehl P, Knuf M, Emschermann T, and others. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000;83:667-672.
24. Bjorkhem G, Lundstrom NR. Echocardiographic studies of children operated on for congenital heart disease; evaluation during the first postoperative year. Eur J Cardiol 1980;11:33-50.
25. Meyer RA, Korfhagen JC, Covitz W, Kaplan S. Long-term follow-up study after closure of secundum atrial septal defect in children: An echocardiographic study. Am J Cardiol 1982;50:143-148.
26. Pearlman AS, Borer JS, Clark CE, Henry WL, Redwood DR, Morrow AG, Epstein SE. Abnormal right ventricular size and ventricular septal motion after atrial septal defect closure: Etiology and functional significance. Am J Cardiol 1978;41:295-301.
27. Du ZD, Cao QL, Koenig P, Heitschmidt M, Hijazi ZM. Speed of normalization of right ventricular volume overload after transcatheter closure of atrial septal defect in children and adults. Am J Cardiol 2001;88:1450-1453, A9.
28. Kort HW, Balzer DT, Johnson MC. Resolution of right heart enlargement after closure of secundum atrial septal defect with transcatheter technique. J Am Coll Cardiol 2001;38:1528-1532.
29. Pedra CA, Pihkala J, Lee KJ, Boutin C, Nykanen DG, McLaughlin PR, Harrison DA, Freedom RM, Benson L. Transcatheter closure of atrial septal defects using the Cardio-Seal implant. Heart 2000;84:320-326.
30. Veldtman GR, Razack V, Siu S, El-Hajj H, Walker F, Webb GD, Benson LN, McLaughlin PR. Right ventricular form and function after percutaneous atrial septal defect device closure. J Am Coll Cardiol 2001;37:2108-2113.
31. Meijboom F, Hess J, Szatmari A, Utens EM, McGhie J, Deckers JW, Roelandt JR, Bos E. Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young age. Am J Cardiol 1993;72:1431-1434.
32. Yew G, Wilson NJ. Transcatheter atrial septal defect closure with the Amplatzer septal occluder: Five-year follow-up. Catheter Cardiovasc Interv 2005;64:193-196.
33. Bonow RO, Borer JS, Rosing DR, Bacharach SL, Green MV, Kent KM. Left ventricular functional reserve in adult patients with atrial septal defect: Pre- and postoperative studies. Circulation 1981;63:1315-1322.
34. Louie EK, Lin SS, Reynertson SI, Brundage BH, Levitsky S, Rich S. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation 1995;92:819-824.
35. Hart JP, Cabreriza SE, Walsh RF, Printz BF, Blumenthal BF, Park DK, Zhu AJ, Gallup CG, Weinberg AD, Hsu DT, et al. Echocardiographic analysis of ventricular geometry and function during repair of congenital septal defects. Ann Thorac Surg 2004;77:53-60.
36. Giardini A, Donti A, Formigari R, Specchia S, Prandstraller D, Bronzetti G, Bonvicini M, Picchio FM. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol 2004;43:1886-1891.
37. Iivainen TE, Groundstroem KW, Lahtela JT, Talvensaari TJ, Pasternack A, Uusitalo A. Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect. Eur J Heart Fail 2000;2:161-165.
38. Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM. Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 2004;25:347-353.
39. Seghaye MC, Duchateau J, Bruniaux J, Demontoux S, Detruit H, Bosson C, Lecronier G, Mokhfi E, Serraf A, Planche C. Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations. Crit Care Med 1997;25:1063-1070.
40. Brancaccio G, Michielon G, Di Donato RM, Costa D, Falzea F, Miraldi F. Atrial natriuretic factor in normothermic and hypothermic cardiopulmonary bypass. Perfusion 2004;19:157-162.
41. Weber M, Dill T, Deetjen A, Neumann T, Ekinci O, Hansel J, Elsaesser A, Mitrovic V, Hamm C. Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients. Heart 2006;92:671-675.
42. Muta H, Ishii M, Maeno Y, Akagi T, Kato H. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002;91:649-652.
43. Attenhofer Jost CH, Oechslin E, Seifert B, Maly F, Fatio R, Turina J, Jenni R. Remodelling after surgical repair of atrial septal defects within the oval fossa. Cardiol Young 2002;12:506-512.